GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | CTH | decreases expression | EXP | | 6480464 | CTD | Lipopolysaccharides results in decreased expression of CTH mRNA; Lipopolysaccharides results in decreased expression of CTH protein | PMID:29128401 | CTH | multiple interactions | EXP | | 6480464 | CTD | TLR4 mRNA promotes the reaction [Lipopolysaccharides results in decreased expression of CTH protein] | PMID:29128401 | CTH | decreases expression | ISO | Cth (Rattus norvegicus) | 6480464 | CTD | Lipopolysaccharides results in decreased expression of CTH protein | PMID:21308383 | CTH | increases expression | ISO | Cth (Rattus norvegicus) | 6480464 | CTD | Lipopolysaccharides results in increased expression of CTH mRNA | PMID:16491094 | CTH | increases response to substance | ISO | Cth (Mus musculus) | 6480464 | CTD | CTH protein mutant form results in increased susceptibility to Lipopolysaccharides | PMID:29128401 | CTH | multiple interactions | ISO | Cth (Rattus norvegicus) | 6480464 | CTD | [Lipopolysaccharides results in decreased expression of CTH protein] which results in decreased chemical synthesis of Hydrogen Sulfide; Cysteine analog promotes the reaction [[Lipopolysaccharides results in decreased expression of CTH protein] which results in decreased chemical synthesis of Hydrogen Sulfide]; nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of CTH mRNA] | PMID:16491094 PMID:21308383 | CTH | multiple interactions | ISO | Cth (Mus musculus) | 6480464 | CTD | [CTH protein mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL4 mRNA; [CTH protein mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL4 protein; [CTH protein mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL6 protein; CTH protein mutant form promotes the reaction [Lipopolysaccharides results in increased expression of IL2 mRNA]; CTH protein mutant form promotes the reaction [Lipopolysaccharides results in increased expression of IL2 protein]; CTH protein mutant form promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; CTH protein mutant form promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; CTH protein mutant form promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Lipopolysaccharides promotes the reaction [CTH protein mutant form results in increased expression of IL2 mRNA]; Lipopolysaccharides promotes the reaction [CTH protein mutant form results in increased expression of IL2 protein]; Lipopolysaccharides promotes the reaction [CTH protein mutant form results in increased expression of IL4 mRNA]; Lipopolysaccharides promotes the reaction [CTH protein mutant form results in increased expression of IL4 protein]; Lipopolysaccharides promotes the reaction [CTH protein mutant form results in increased expression of IL6 mRNA] | PMID:29128401 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |